Published on
February 6, 2024
- 16:00 GMT
Strategikon Closes Series A1 Funding Round to Modernize Clinical Trials Business Operations Worldwide
Led by Osage Venture Partners, Debiopharm, HearstLab, and Golden Seeds SAN FRANCISCO, CA, USA, February 6, 2024 /EINPresswire.com/ -- Strategikon, provider of cloud-based solutions that optimize and accelerate the budgeting, planning, outsourcing, and …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
